Most recently, it has been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to a big range of endogenous opioids. Unlike most opioid receptors, this receptor acts to be a scavenger https://samuele453hiq2.oblogation.com/profile